Current and Past PROPEL Participating Companies
Advanced Cooling Therapy
Advanced Cooling Therapy, LLC, is developing innovative, novel, patent-pending devices to modify and control patient temperature. These innovative biomedical devices provide a revolutionary approach to induce mild therapeutic hypothermia, maintain normothermia, and reduce fever. They are safer, more effective, and easier to use than existing devices, while doubling patient survival at less than half the cost of competitors. Contact info@advancedcoolingtherapy.com for more information.
Ag-Defense Systems, Inc.
Ag-Defense Systems is developing technology with real-time reporting capability for on-site monitoring in the $1.25 trillion food processing industry. Food contamination leads to over 75 million illnesses per year. The portable BioSage will be used to detect pathogens within minutes while employing GPS tracking capabilities so that as the threat of food supply contamination grows, Ag-Defense Systems will be ready to monitor and alert people in realtime.
American BioOptics
American BioOptics is a medical device company located in Evanston, Illinois. The company is working to revolutionize colon cancer screening, and eventually screening of other cancers, with a highly accurate, minimally invasive test based on a novel light-scattering technology platform.
Aqualung Therapeutics, Corp.
Aqualung Therapeutics is developing innovative tools to prevent, diagnose and treat fluid accumulation in the lungs or pulmonary edema for inflammatory lung disorders that include acute lung injury, asthma, pulmonary hypertension, sarcoidosis, idiopathic pulmonary fibrosis and lung complications of sickle cell disease. A particular focus is on critically ill patients who often have respiratory failure but have limited treatment options other than mechanical ventilation, which itself can contribute to the inflammatory lung processes. For more information, contact aqualungtherapeutics@gmail.com.
Assistive Medical Equipment Corp.
Assistive Medical Equipment is improving ease of care for the elderly and disabled by manufacturing and selling the MAX-MOVE™ transfer system. MAX-MOVE allows one nurse to transfer a patient without the lifting and bending that cause high lower-back injury rates. MAX-MOVE helps hospital and nursing facilities comply with new safe patient handling legislation. Utility patents are pending and commercial prototypes are being evaluated. For more information, contact jim@assistiveme.com.
B&H Biotechnologies, LLC
B&H Biotechnologies seeks to develop novel diagnostic, preventative (including new vaccines) and therapeutic products for infections, autoimmune diseases and cancers by revealing the pathogenic mechanisms of these diseases.
Cell Habitats, Inc.
Cell Habitats, Inc. is an early-stage biomedical device company developing an easy-to-administer, micro device that allows the natural repair and regeneration of damaged tissue. Its first application will be to restore normal cardiac function after a heart attack. For more information, contact cellhabitats@gmail.com.
Corvida Medical
Corvida Medical is an emerging medical device company commercializing innovative technology to optimize safety, increase efficiency and reduce the cost of preparing and delivering hazardous medications, such as chemotherapy. Hospital pharmacies and oncology clinics create a $500 million U.S. market potential, with a current market opportunity in excess of $100 million growing over 25 percent annually. The company has pending patents, proven technology, experienced management, reputable advisors and written commitments from leading cancer centers as beta sites/launch customers, culminating in successful Series A Financing.
Functional Circulation
Functional Circulation is an Illinois biotech developing in vitro organ reanimation technologies for scientific and clinical applications. The company makes products and services that apply proprietary technologies to the understanding and treatment of organ-related disease.
Gene Smart Diagnostics
Positioned to become a leader in the large, fast-growing personalized health market, Gene Smart Diagnostics is an early-stage healthcare company that develops and markets proprietary genetic tests and related products to prevent serious diseases and disorders in genetically susceptible individuals. The company’s patented technologies are focused on central pathways and associated gene clusters related to a range of emotional and cognitive disorders, inflammatory and autoimmune diseases and cancers.
Kim Laboratories, Inc.
Kim Laboratories is the developer of the NoroCheck™ and ValidCheck™ pathogen detection systems for the real-time detection of food-borne pathogens. The company produces its detection instruments and test kits and sells them globally to food manufacturers and processors, school cafeterias, restaurant suppliers, water testing companies and government agencies. Kim Laboratories also produces an array of diagnostic reagents for the detection of pathogens such as salmonella, E. coli O157:H7 and norovirus. For more information, contact sales@kimlaboratories.com.
Lincoln Advanced Technologies, LLC
Lincoln Advanced Technologies is a development-stage producer of health and safety equipment for government, industry and critical infrastructure segments of the U.S. economy.
Nerve Access, Inc.
Nerve Access is a pharmaceutical company founded to conduct quality research for and manufacturing of pharmaceuticals and related medical products, with a special focus on therapeutics that can enhance regeneration and functional recovery of the central nervous system after neurological disorders such as traumatic brain injury, stroke, Alzheimer's, Parkinson's, spinal cord injury and multiple sclerosis. Nerve Access is currently working to develop a drug for Alzheimer's with a novel route of administration. For more information, email contact@nerveaccess.com.
NuCurrent
NuCurrent is a wireless power company defining the cutting edge of high efficiency antennas and electrical components for wireless systems in medical devices. For more information, contact jacob.babcock@nucurrent.com.
ProSorp BioTech, Inc.
ProSorp BioTech is an early-stage medical device company engaged in the development and commercialization of a new generation of advanced blood management therapies through targeted filtration of undesirable compounds and proteins involved in inflammation for patients with chronic disease states such as diabetes and kidney disease. For more information, contact kathyhe03@yahoo.com.
Resonance Medical Technologies, Inc
Resonance Medical Technologies Inc. is developing a minimally invasive solution for targeted drug delivery to the sensory cells of the inner ear with the goal of reversing hearing loss. RMT will facilitate the creation of an entirely new set of therapies that center around the delivery of drugs and biologics directly to the ear. Our technique uses the ear canal as an orifice through which drugs are delivered using pump technology and pharmaceuticals that are readily available. For more information, contact ahebron311@gmail.com.
Stabilis
One in three senior citizens falls each year, resulting in $19 billion in annual US healthcare costs and an immeasurable cost to elders living with the fear of falling. Stabilis Company is proud to bring you OptiBalance, the first groundbreaking solution to this problem. Backed by $4.3 million NIH research dollars, OptiBalance is a revolutionary new type of physical therapy equipment that prevents slip and trip related falls by 90% for 6 months after just one 30-minute session.
Stone Medical Corporation
Stone Medical is dedicated to providing the Clean Collect Blood Collection System to hospitals and clinical laboratories worldwide. The Clean Collect Blood Collection System is a development-stage product line that prevents the contamination of blood cultures, a $3.7 billion problem annually for hospitals worldwide. For more information, contact info@stonemedcorp.com.
Surgimatix, Inc.
Surgimatix is an early-stage company that is developing medical devices for wound closure. Its product development efforts are the result of close collaboration between experienced engineers and surgeons. The mission of the company is to commercialize products that improve clinical outcomes while increasing efficiency, patient comfort and safety. For more information, contact info@surgimatix.com.
Sword Diagnostics
Sword Diagnostics dramatically improves the detection of low concentrations of biomarkers (indicators of the presence of disease) in immunoassays and easily integrates into existing tests. By detecting lower concentrations of these biomarkers, earlier disease detection is possible, improving treatment options and the probability of recovery. Sword Diagnostics’ Raman spectroscopy-based detection technology is targeted for life sciences research, drug discovery and clinical diagnostics.
Vidasym
Vidasym is a biotech company developing vitamin D receptor modulators to manage renal disease progression and complications associated with chronic kidney disease. Its platform has several advantages including a strong management team, a huge untapped market and well-established development and regulatory paths with access to FDA-approved biomarkers.